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ABSTRACT
Primary thyroid lymphoma is a rare cause of both thyroid malignancy and extra-nodal lymphoma. It typically presents as a rapidly enlarging 
goitre with compressive symptoms. Histological analysis of a biopsy specimen is necessary to confirm the diagnosis. Awareness of this 
disease is important for early diagnosis and appropriate treatment. A 55-year-old man was admitted due to a 3-month history of cervical 
enlargement, facial and periorbital oedema and dyspnoea, apparently due to a superior vena cava syndrome. However, cervical ultrasound 
showed asymmetrical thyroid enlargement, lobulated contours and a hypoechogenic texture. A neck CT scan showed calibre reduction of 
the superior vena cava. The diagnosis of primary thyroid lymphoma was confirmed by open biopsy of the thyroid gland. The patient started 
treatment with rituximab with clinical improvement.
LEARNING POINTS
• Primary thyroid lymphoma is rare, accounting for less than 5% of thyroid malignancies and less than 2% of extra-nodal lymphomas, but 
should be suspected in the presence of a rapidly enlarging goitre.
• Fine needle aspiration biopsy is the initial technique of choice, but core needle biopsy or open surgical biopsy may be necessary to 
establish the diagnosis.
• Treatment and prognosis are dependent on accurate histological classification, with the disease generally treated successfully with 
chemotherapy.
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INTRODUCTION
Primary thyroid lymphoma (PTL) is an uncommon tumour, estimated to account for approximately 5% of all thyroid neoplasms. Diffused 
large B-cell lymphoma and extra-nodal marginal zone lymphoma of mucosa-associated lymphoid tissue constitute more than 90% of cases[1, 2]. 
Follicular lymphoma (FL) accounts for 3–5% of all PTLs, and is one of the most common forms of non-Hodgkin lymphoma (NHL), with an 
estimated incidence in Europe of 2.18 cases per 100,000 persons per year. Thyroid NHL accounts for approximately 1.2–1.7% of all NHL[3,4].
Patients with PTL most commonly present in their sixties, with women being more frequently affected (female:male ratio ranging from 2:1 
to 8:1). It typically presents as a rapidly enlarging goitre with compressive symptoms and cervical lymphadenopathy. A definitive diagnosis 
of PTL requires histological tissue analysis[4,5]. It is very curable without the need for extensive surgery, so early recognition and correct 
treatment is vital[3–5].
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CASE PRESENTATION
We describe the case of a 55-year-old man admitted with a progressive increase in cervical diameter, associated with facial and periorbital 
oedema and dyspnoea that had started 3 months previously. He reported several episodes of syncope on standing or sitting up rapidly, on 
elevation of his arms above his head and during bathing. He did not have fever, weight loss, anorexia, asthenia or sweating. He had a personal 
history of hypertension, dyslipidaemia and multinodular goitre. Chronic medications included levothyroxine (0.1 mg/day), irbesartan (150 
mg/day), atorvastatin (10 mg/day) and pantoprazole (40 mg/day). There was no history of alcohol abuse or illicit drug use. He did not refer 
high-risk sexual exposures and did not report recent travel. Regarding family history, his brother had been diagnosed with a lymphoma in 
middle age and had died.
On physical evaluation, the patient was afebrile and haemodynamically stable, with cervical, facial, periorbital and upper-extremity oedema, 
an enlarged thyroid, and venous dilation of the neck and chest wall, suggesting a superior vena cava syndrome. Blood work-up only revealed 
a slightly increased C-reactive protein of 2.31 mg/dl (normal value <0.5 mg/dl), and the thyroid hormones were within the normal range.
The patient underwent a cervical ultrasound that revealed an asymmetrical thyroid, with greatly enlarged dimensions, discreetly lobulated 
contours and a markedly hypoechogenic texture. Multiple ganglionic formations were observed with bilaterally oval morphology, some of 
them necrotic, the largest on the left being 15×15 mm in size and on the right 17×11 mm, with the morphological and dimensional criteria 
of adenopathies. A neck CT scan showed densification of fat in the upper mediastinum, calibre reduction of the superior vena cava, two 
adenopathies measuring 22×14 mm and 17×12 mm in a pre-tracheal location, and also fat densification in the plane of the carina (Fig. 1). 
Consequently, phlebography of the central vessels was performed and showed pre-occlusive stenosis of the superior vena cava involving the 
brachiocephalic venous trunks, with left brachiocephalic venous trunk thrombosis. Two stents were placed with recovery of permeability 
and evident clinical improvement. Fine needle aspiration cytology of cervical adenopathy was inconclusive. Thus, surgical intervention was 
performed with open biopsy of the thyroid gland, whose histological result was compatible with follicular thyroid B lymphoma. 
For staging the disease, a fluorodeoxyglucose (FDG) positron emission tomography (PET) scan was performed, revealing high-grade 
hypermetabolic lymphomatous disease, with supra-diaphragmatic lymph node involvement forming adenopathic conglomerates without 
cleavage planes with the thyroid gland (Fig. 2). The patient was treated with rituximab with disease remission.
Figure 1. Neck CT scan showing densification of 
fat in the upper mediastinum, calibre reduction 
of the superior vena cava and fat densification 
in the plane of the carina
Figure 2. PET showing high-grade hypermetabolic lymphomatous disease, with supra-diaphragmatic lymph node 
involvement forming adenopathic conglomerates without cleavage planes with the thyroid 
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DISCUSSION
PTL is a rare type of thyroid cancer, accounting for 1–2% of all extra- nodal lymphomas, with FL representing only 3–5% of all PTLs. There are 
several different types of lymphoma and determining the exact type is essential for treatment selection and prognosis[1,3,4].
The most common presentation is a rapidly enlarging thyroid mass. Other symptoms such as dyspnoea, dysphagia and hoarseness may 
arise as a result of mass effects. Rarely stridor or superior vena cava obstruction may occur. B-type symptoms such as weight loss and night 
sweats occur less commonly and have been reported in approximately 20% of patients[1,4]. 
Despite its rarity, PTL should always be considered in a patient with a rapidly growing goitre or thyroid nodules, bearing in mind that about 
30–60% of patients are biochemically euthyroid at presentation[3–5]. 
Cervical ultrasonography is a standard initial imaging modality, showing thyroid patterns that may suggests the diagnosis. Once the diagnosis 
of PTL has been established, a CT scan of the entire body is necessary in order to stage the patient accurately. FDG PET scanning appears to 
be a good imaging modality for assessing the extent of PTL[3,4].
Histological analysis is necessary to confirm the diagnosis, with the best method being to perform a tissue biopsy. Fine needle aspiration 
biopsy is the initial technique of choice but is often not able to obtain enough cells for an accurate diagnosis. In these cases, core needle 
biopsy or open surgical biopsy may be necessary[1,3].
The optimal treatment for PTL remains controversial because of limited evidence. As with other lymphomas, PTL is sensitive to both 
chemotherapy and radiotherapy. Most PTL is treated successfully with chemotherapy with rituximab alone or in combination with other 
chemotherapeutic agents. Therefore, surgery is rarely required for treatment. The prognosis is generally excellent but is dependent on the 
subtype of lymphoma[1,3,4]. 
Although PTL is a rare cause of both thyroid malignancy and extra-nodal lymphoma, awareness of this disease is important in order to 
achieve an early diagnosis and implement suitable treatment[4].
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